- Home
- ACHC vs LNTH Comparison
ACHC vs LNTH Comparison
Compare ACHC & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ACHC | LNTH |
|---|---|---|
| Founded | 2005 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 4.4B |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | ACHC | LNTH |
|---|---|---|
| Price | $14.42 | $66.17 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 13 | 6 |
| Target Price | $24.00 | ★ $78.00 |
| AVG Volume (30 Days) | ★ 3.6M | 1.2M |
| Earning Date | 11-05-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | 1.18 | ★ 2.39 |
| Revenue | ★ $3,265,548,000.00 | $1,525,933,000.00 |
| Revenue This Year | $6.50 | $0.01 |
| Revenue Next Year | $4.38 | $1.24 |
| P/E Ratio | ★ $12.22 | $27.55 |
| Revenue Growth | ★ 4.58 | 1.95 |
| 52 Week Low | $12.63 | $47.25 |
| 52 Week High | $47.08 | $111.29 |
Technical Indicators
Market Signals| Indicator | ACHC | LNTH |
|---|---|---|
| Relative Strength Index (RSI) | 36.71 | 67.34 |
| Support Level | $13.95 | $64.13 |
| Resistance Level | $14.94 | $67.01 |
| Average True Range (ATR) | 0.85 | 2.17 |
| MACD | 0.21 | 0.32 |
| Stochastic Oscillator | 42.35 | 84.68 |
Price Performance
Historical ComparisonAbout ACHC Acadia Healthcare Company Inc.
Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The company's revenue is derived from services rendered to patients for inpatient psychiatric and substance abuse care, outpatient psychiatric care, and adolescent residential treatment.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.